skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Effects of subtoxic concentrations of TiO{sub 2} and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production

Journal Article · · Toxicology and Applied Pharmacology
; ;  [1]; ;  [2];  [1];  [1]
  1. Translational Immunology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm (Sweden)
  2. Laboratory for Materials — Biology Interactions, Swiss Federal Laboratories of Materials Testing and Research, St. Gallen (Switzerland)

Metal oxide nanoparticles are widely used in the paint and coating industry as well as in cosmetics, but the knowledge of their possible interactions with the immune system is very limited. Our aims were to investigate if commercially available TiO{sub 2} and ZnO nanoparticles may affect different human immune cells and their production of exosomes, nano-sized vesicles that have a role in cell to cell communication. We found that the TiO{sub 2} or ZnO nanoparticles at concentrations from 1 to 100 μg/mL did not affect the viability of primary human peripheral blood mononuclear cells (PBMC). In contrast, monocyte-derived dendritic cells (MDDC) reacted with a dose dependent increase in cell death and caspase activity to ZnO but not to TiO{sub 2} nanoparticles. Non-toxic exposure, 10 μg/mL, to TiO{sub 2} and ZnO nanoparticles did not significantly alter the phenotype of MDDC. Interestingly, ZnO but not TiO{sub 2} nanoparticles induced a down regulation of FcγRIII (CD16) expression on NK-cells in the PBMC population, suggesting that subtoxic concentrations of ZnO nanoparticles might have an effect on FcγR-mediated immune responses. The phenotype and size of exosomes produced by PBMC or MDDC exposed to the nanoparticles were similar to that of exosomes harvested from control cultures. TiO{sub 2} or ZnO nanoparticles could not be detected within or associated to exosomes as analyzed with TEM. We conclude that TiO{sub 2} and ZnO nanoparticles differently affect immune cells and that evaluations of nanoparticles should be performed even at subtoxic concentrations on different primary human immune cells when investigating potential effects on immune functions. -- Highlights: ► ZnO nanoparticles induce cell death of MDDC but not of PBMC. ► ZnO nanoparticles induce caspase activation and DNA fragmentation in MDDC. ► TiO{sub 2} nanoparticles are taken up by MDDC but have no effect on their phenotype. ► ZnO nanoparticles induce a significant reduction of CD16 expression on NK cells. ► ZnO and TiO{sub 2} nanoparticles have no effect on exosomes produced by MDDC or PBMC.

OSTI ID:
22215928
Journal Information:
Toxicology and Applied Pharmacology, Vol. 264, Issue 1; Other Information: Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English